NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Zydus to seek approval for its COVID-19 vaccine next week
    India

    Zydus to seek approval for its COVID-19 vaccine next week

    Zydus to seek approval for its COVID-19 vaccine next week
    Written by Sagar
    Jun 19, 2021, 01:00 pm 3 min read
    Zydus to seek approval for its COVID-19 vaccine next week
    Gujarat-based firm Zydus Cadila will soon seek emergency use approval for its coronavirus vaccine in India.

    Zydus Cadila, the Gujarat-based drug firm, will next week apply for the emergency use authorization (EUA) of its COVID-19 vaccine in India, company sources told the media, adding it has apprised the government of its intention. If and when approved, the vaccine, named ZyCoV-D, will become the world's first DNA vaccine against the coronavirus and the fourth jab to get the nod in India.

    Data from Zydus's phase three trial is nearly ready

    Data from the company's latest clinical trial is now almost ready, a source told PTI. "Zydus Cadila has told the government that it could apply for emergency use authorization for ZyCoV-D vaccine in the next seven-eight days," news agency ANI quoted a government source as saying. Zydus had enrolled more than 28,000 volunteers for their phase three trial, according to a top government official.

    It is reportedly the first COVID-19 vaccine with 3 doses

    What makes this vaccine distinct from other jabs approved around the world is it is a DNA vaccine, implying it contains such genetic material that will instruct the human cells to produce coronavirus antigen. It is also reportedly the first vaccine with a three-dose regimen. The second and third doses are required to be given 28 and 56 days after the first, respectively.

    It could be India's first approved jab for children

    Zydus's phase three trial also included children aged between 12 and 18 years. Hence, if this vaccine gets the due approval from the Drugs Controller General of India (DCGI) - it could go on to become the country's first approved jab for the below 18 population. Bharat Biotech is also notably carrying out trials on children, but they are still in an initial phase.

    It does not require ultra-cold temperatures

    ZyCoV-D has been supported by the central government's National Biopharma Mission (NBM) under the aegis of the Biotechnology Industry Research Assistance Council, a public sector undertaking. Reports say the vaccine can be stored at two to four degree Celsius and does not require cold chains, which will potentially make its transportation to remote areas of the country easier and cheaper.

    'We are very proud of their work,' government official says

    The Indian government has praised Zydus's efforts in giving India its second indigenous COVID-19 vaccine. "We expect they will submit the results very soon...We are very proud of their work," Dr. VK Paul, who is overseeing the country's COVID-19 fight, told ANI.

    Zydus could provide about 5 crore doses by December

    However, even if Zydus earns the go-ahead from India's top drug regulator, it would not be a huge addition to India's ambitious inoculation program, in terms of volume. That is because of the company's relatively limited manufacturing capacity. The government says the firm could provide around five crore vaccine doses between this August and December.

    Nearly 16% Indians are partially vaccinated

    India has three approved coronavirus vaccines - COVAXIN, Oxford-AstraZeneca's Covishield, and Russia's Sputnik V. More than 26 crore vaccine doses have been administered in India, however, only 3.5% of the population is fully vaccinated. That's partly because India's most prevalent vaccine has a dose gap of at least 12 weeks. The government aims to inoculate all Indian adults by the end of this year.

    Third wave likely in 6 to 8 weeks, expert warns

    India faced the world's worst coronavirus outbreak over the past couple of months. Daily cases in the country had peaked at 4,14,000 in early May. The situation has since improved, with new infections hovering around 60,000 over the past few days. However, a new wave of COVID-19 could hit India within the next eight weeks, AIIMS chief Dr. Randeep Guleria has warned.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    India
    Zydus Cadila
    Coronavirus
    COVID-19

    Latest

    'Farzi' to 'Thunivu': Exciting OTT weekend watchlist is here OTT releases
    Here's how to come out of a toxic relationship  Relationships
    Lifeguards in Goa get AI assistance for rescue operations Goa
    Valentine's Week: 12 modern Bollywood romantic songs you cannot miss! Bollywood

    India

    Death toll from earthquake in Turkey and Syria nears 8,000 Earthquake
    Indian-American teen Natasha Perianayagam named "world's brightest" student once again World
    India sends first batch of relief aid to earthquake-hit Turkey Turkey
    24-year-old Indian-origin student makes history; to head Harvard Law Review Harvard

    Zydus Cadila

    Are Indian vaccines effective against Omicron? Here's what manufacturers say Coronavirus
    ZyCoV-D expected to be rolled out in two weeks: Report Coronavirus
    Here are some key drugs being tested for COVID-19 treatment Pfizer
    NTAGI to devise roadmap to introduce ZyCoV-D into inoculation drive Coronavirus

    Coronavirus

    COVID-19 outbreak has infected 80% of Chinese population China
    COVID-19: WHO urges travelers to mask up amid XBB.1.5 spread World Health Organization
    China: Hospitals cancel New Year holidays to meet patients' requirements China
    #NewsBytesExplainer: What's XBB.1.5, COVID-19 sub-variant triggering cases spike in US  COVID-19

    COVID-19

    Zoom fires 1,300 employees due to "uncertainty of global economy" Zoom
    US reduces visa backlog; appointments for Indians at overseas embassies H-1B Visa
    Kerala: Man gets 3 life-terms for raping, impregnating minor daughter Kerala
    Amid global slowdown predictions, IMF calls India 'bright spot' International Monetary Fund

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023